Shared Resource Cores
共享资源核心
基本信息
- 批准号:8183701
- 负责人:
- 金额:$ 62.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-07-01 至 2018-05-31
- 项目状态:已结题
- 来源:
- 关键词:AffinityAmino AcidsAntibodiesAntibody FormationBindingBiological AssayBody FluidsCOSYCardiacCardiovascular DiseasesCell membraneCell surfaceCellsChemicalsChemistryCollaborationsComplexConsultationsCustomCytoplasmDatabasesDetectionDevelopmentDisciplineDiseaseEnvironmentEnzymesEquipmentGlycoconjugatesGlycolipidsGlycopeptidesGlycoproteinsGoalsGrantHexosaminesIn VitroInstructionIsotope LabelingLabelLaboratoriesLectinLigandsLinkMapsMass Spectrum AnalysisMembrane ProteinsMetabolicMethodologyMethodsMissionModelingModificationMolecular ConformationMonitorNMR SpectroscopyNational Heart, Lung, and Blood InstituteNucleotidesOligosaccharidesPeptide antibodiesPeptidesPhosphorylated PeptidePhosphorylationPhysiologicalPolysaccharidesPost-Translational Protein ProcessingProcessPropertyProtein AnalysisProtein GlycosylationProteinsProteomicsProtocols documentationROESYReagentRegulationRelative (related person)ResearchResearch PersonnelResearch Project GrantsResource SharingResourcesRoleSamplingScreening procedureServicesSiteSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationStable Isotope LabelingStructureTOCSYTechniquesTechnologyTissuesTraininganaloganalytical toolbasedesignextracellularglycosylationglycosyltransferasehuman diseasein vivoinhibitor/antagonistinterestlink proteinprogramsprotein complexskillssmall moleculesugarsugar nucleotidetoolweb site
项目摘要
PROJECT SU MMARY (See instructions):
Analysis of glycoconjugate structure/functions requires specialized expertise from various disciplines.
Many of these tools and approaches are not only difficult, but also require expensive and complex equipment. We have established our Shared Resource Core to not only contain the components that are most essential for the aims of this PEG, but also that build upon the unique strengths of our participating investigators. Each sub-Core is detailed in their separate sections.
Sub-Core 01 - Mass Spectrometry -Drs. van Eyk and Zhang are leaders in mass spectrometric analysis of proteins and glycoproteins. The Core is extraordinarily well equipped. The Core's offerings include: 1) Identification of proteins; 2) global quantification of N-linked or O-linked glycoproteins using solidphase extraction of glycopeptides; 3) Lectin affinity/MS analyses; 4) Monitoring changes in glycosylation by lectin microarrays; 5) The use of "Click" chemistry for analyses of metabolically produced glycoconjugates; 6)Glycan profiling by MALDI-MS" (AXIMA-Resonance) and GlycanAnalyser. 7) Cell surface capture technology for isolation of glycoproteins; 2) Targeted capture of soluble glycoproteins from cytoplasm or extracellular environment; 3) MRM MS/MS assays for targeted quantification ofglycoproteins and glycosylation sites.
Sub-Core C2 - NMR - When possible, glycan structure is best determined by NMR. Dr. Allen Bush is a leading expert in the structural analysis of glycans by NMR. His sub-Core supports the PEG by offering structural expertise for oligosaccharides, polysaccharides, glycopeptides, small glycoproteins and glycolipids. State of the art NMR equipment and methods are available in this sub-Core.
Sub-Core C3 - Chemistry - Dr. Kevin Yarema is a leading chemical glycobiologist. His sub-Core will support the PEGs by: 1) providing sugar analogs for "metabolic glycoengineering" (eg. SCFA-hexosamines);
2) performing custom synthesis of inhibitors (eg. D-PDMP, TMG), azido sugars and sugar nucleotides, glycan-tagging tools and other small molecules.
Sub-Core 04 - 0-GlcNAc Resources - Drs. Hart and Zachara are leaders in the analysis of 0-GlcNAc.
In support of the PEGs we offer: 1) Tools for detecting 0-GlcNAc, OGT and OGA; 2) Develop site-specific 0-GlcNAc antibodies; 3) Provide synthetic 0-GlcNAc peptides for antibody production and MS standards; 4) Assays for OGT and OGA activity; 5) Quantitation of sugar nucleotides & nucleotides; 6) Assist with site mapping and quantification on single proteins or globally. This Shared Resource provides key technologies to allow rapid advancement of glycoscience research critical to the mission of the NHLBI.
SU MMARY项目(请参阅说明):
糖缀合物的结构/功能的分析需要各种学科的专业专业知识。
这些工具和方法中的许多不仅困难,而且需要昂贵且复杂的设备。我们已经建立了共享的资源核心,不仅包含对钉子目标最重要的组成部分,而且还基于参与调查人员的独特优势。每个子核在其单独的部分中详细介绍。
亚核01-质谱 - drs。 Van Eyk和Zhang是蛋白质和糖蛋白质谱分析的领导者。核心设备齐全。核心的产品包括:1)识别蛋白质; 2)使用糖肽的固相提取的N连锁或O连接糖蛋白的全球定量; 3)凝集素亲和力/MS分析; 4)通过凝集素微阵列监测糖基化的变化; 5)使用“点击”化学来分析代谢产生的糖缀合物; 6)MALDI-MS的聚糖分析(Axima-resonance)和糖纳拉塞菌。7)细胞表面捕获技术用于隔离糖蛋白; 2)针对细胞质或细胞外环境中可溶性糖蛋白的靶向捕获; 3)MMM/MS MMS/MS MMS/MS MMS/MS MMS/MS MMM/MS MMM/MS MMM/MS MMS/MS MMM/MSS分析。
亚核C2 -NMR-在可能的情况下,聚糖结构最好由NMR确定。艾伦·布什(Allen Bush)博士是NMR对聚糖结构分析的领先专家。他的子核通过提供寡糖,多糖,糖肽,小糖蛋白和糖脂的结构专业知识来支持PEG。该子核心有最先进的NMR设备和方法。
亚核C3-化学-Kevin Yarema博士是领先的化学糖生物学家。他的子核将通过:1)提供“代谢糖工程”的糖类似物(例如SCFA-HEXOSAMINE);
2)执行抑制剂(例如D-PDMP,TMG),氮杂糖和糖核苷酸的自定义合成,聚糖引用工具和其他小分子。
子核04-0 -GLCNAC资源-DRS。 Hart和Zachara是0-GLCNAC分析的领导者。
为了支持PEG,我们提供的:1)用于检测0-GLCNAC,OGT和OGA的工具; 2)开发特异性的0-GLCNAC抗体; 3)为抗体产生和MS标准提供合成0-GLCNAC肽; 4)OGT和OGA活动的测定; 5)糖核苷酸和核苷酸的定量; 6)在单蛋白或全球范围内协助站点映射和定量。该共享资源提供了关键技术,以允许对NHLBI使命至关重要的糖基科学研究的快速发展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GERALD Warren HART其他文献
GERALD Warren HART的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GERALD Warren HART', 18)}}的其他基金
Regulation of Translation by O-GlcNAc - Resubmission 03-05-2020
O-GlcNAc 翻译调节 - 重新提交 03-05-2020
- 批准号:
10308411 - 财政年份:2020
- 资助金额:
$ 62.86万 - 项目类别:
Regulation of Translation by O-GlcNAc - Resubmission 03-05-2020
O-GlcNAc 的翻译调节 - 重新提交 03-05-2020
- 批准号:
10533317 - 财政年份:2020
- 资助金额:
$ 62.86万 - 项目类别:
Nutrient Regulation of Cell Physiology by O-GlcNAcylation
O-GlcNAc 酰化对细胞生理学的营养调节
- 批准号:
10458006 - 财政年份:2016
- 资助金额:
$ 62.86万 - 项目类别:
Nutrient Regulation of Cell Physiology by O-GlcNAcylation
O-GlcNAc 酰化对细胞生理学的营养调节
- 批准号:
10261390 - 财政年份:2016
- 资助金额:
$ 62.86万 - 项目类别:
Nutrient Regulation of Cell Physiology by O-GlcNAcylation
O-GlcNAc 酰化对细胞生理学的营养调节
- 批准号:
10668984 - 财政年份:2016
- 资助金额:
$ 62.86万 - 项目类别:
Nutrient Regulation of Cell Physiology by O-GlcNAcylation
O-GlcNAc 酰化对细胞生理学的营养调节
- 批准号:
9329448 - 财政年份:2016
- 资助金额:
$ 62.86万 - 项目类别:
Nutrient Regulation of Cell Physiology by O-GlcNAcylation
O-GlcNAc 酰化对细胞生理学的营养调节
- 批准号:
9754184 - 财政年份:2016
- 资助金额:
$ 62.86万 - 项目类别:
相似国自然基金
PEDV变异株逃逸经典株中和抗体关键氨基酸位点的解析
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
PEDV变异株逃逸经典株中和抗体关键氨基酸位点的解析
- 批准号:32202823
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
聚氨基酸用于蛋白质翻译后修饰泛抗体的诱导与制备
- 批准号:22105008
- 批准年份:2021
- 资助金额:20 万元
- 项目类别:青年科学基金项目
基于非天然氨基酸光交联的表位靶向抗体筛选及其应用研究
- 批准号:
- 批准年份:2020
- 资助金额:58 万元
- 项目类别:面上项目
磷酸化组氨酸(pHis)的抗体富集、质谱鉴定及生物功能研究
- 批准号:91953103
- 批准年份:2019
- 资助金额:60.0 万元
- 项目类别:重大研究计划
相似海外基金
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
- 批准号:
10491642 - 财政年份:2023
- 资助金额:
$ 62.86万 - 项目类别:
Biotin Orthogonal Streptavidin System (BOSS) for Drug Pre-Targeting
用于药物预靶向的生物素正交链霉亲和素系统 (BOSS)
- 批准号:
10606180 - 财政年份:2023
- 资助金额:
$ 62.86万 - 项目类别:
Single-molecule protein sequencing by barcoding of N-terminal amino acids
通过 N 端氨基酸条形码进行单分子蛋白质测序
- 批准号:
10757309 - 财政年份:2023
- 资助金额:
$ 62.86万 - 项目类别:
Scalable platforms for understudied histone modifications and modifiers
用于未充分研究的组蛋白修饰和修饰剂的可扩展平台
- 批准号:
10567849 - 财政年份:2023
- 资助金额:
$ 62.86万 - 项目类别:
Diagnostic aptamer reagents to develop multi-analyte blood test for pre-clinical, mild and moderate Alzheimer's disease
诊断适体试剂用于开发针对临床前、轻度和中度阿尔茨海默病的多分析物血液检测
- 批准号:
10597840 - 财政年份:2023
- 资助金额:
$ 62.86万 - 项目类别: